Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study

BACKGROUND: Rilpivirine is safe and effective in HIV-naïve patients with low baseline HIV-RNA or in switch strategy. It offers the advantages of few drug-drug interactions and a favourable toxicity profile. We aimed to determine the reasons for prescribing the rilpivirine (RPV)/tenofovir disoproxil...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Sculier, Delphine, Gayet-Ageron, Angèle, Battegay, Manuel, Cavassini, Matthias, Fehr, Jan, Hirzel, Cedric, Schmid, Patrick, Bernasconi, Enos, Calmy, Alexandra
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500925/
https://ncbi.nlm.nih.gov/pubmed/28683720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2579-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados